Correlation Between BioNTech and Omni Health
Can any of the company-specific risk be diversified away by investing in both BioNTech and Omni Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Omni Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and Omni Health, you can compare the effects of market volatilities on BioNTech and Omni Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Omni Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Omni Health.
Diversification Opportunities for BioNTech and Omni Health
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between BioNTech and Omni is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Omni Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Omni Health and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Omni Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Omni Health has no effect on the direction of BioNTech i.e., BioNTech and Omni Health go up and down completely randomly.
Pair Corralation between BioNTech and Omni Health
If you would invest 0.00 in Omni Health on September 20, 2024 and sell it today you would earn a total of 0.00 from holding Omni Health or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
BioNTech SE vs. Omni Health
Performance |
Timeline |
BioNTech SE |
Omni Health |
BioNTech and Omni Health Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BioNTech and Omni Health
The main advantage of trading using opposite BioNTech and Omni Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Omni Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omni Health will offset losses from the drop in Omni Health's long position.BioNTech vs. Novavax | BioNTech vs. Ginkgo Bioworks Holdings | BioNTech vs. Crispr Therapeutics AG | BioNTech vs. Ocean Biomedical |
Omni Health vs. Caf Serendipity Holdings | Omni Health vs. Green Cures Botanical | Omni Health vs. Vapor Group | Omni Health vs. Ubiquitech Software |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |